Low Molecular Weight Heparin (Reviparin) in Preventing Mortality, Reinfarction, and Strokes in Over 15,500 Patients With ST Elevation Acute Myocardial Infarction - CREATE ELCA - Reviparin

Description:

The goal of the trial was to evaluate treatment with the low molecular weight heparin reviparin compared with placebo in patients with acute myocardial infarction (MI).